Climb Bio CLYM
NASDAQ CLYM
$11.74 +0.73 (+6.63%)
At close: Nov 10, 2026 · 4:00 PM EST

Climb Bio (CLYM) Common Stock Issued (2021 - 2026)

Updated

Analysis

Climb Bio (CLYM) Common Stock Issued (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 743.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 247.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 87.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Climb Bio 871.20 Mn 390.53 Mn - 103.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 103.70 Mn
Mar 31, 2026 5,000.00
Dec 31, 2025 65,000.00
Dec 31, 2024 41,000.00
Sep 30, 2024 2.27 Mn
Mar 31, 2024 15,000.00
Dec 31, 2023 288,000.00
Sep 30, 2023 528,000.00
Jun 30, 2023 24,000.00
Mar 31, 2023 1,000.00
Dec 31, 2021 -83.11 Mn
Sep 30, 2021 83.14 Mn
Jun 30, 2021 6,000.00
Mar 31, 2021 105,000.00
API Access

Climb Bio Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=CLYM&period=max&api_key=YOUR_API_KEY